Minerva Neurosciences, Inc. (NERV) stock
NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.16−0.04 (-1.82%)
Close on Nov 17, 2026Market cap $103.14MP/E –Yield –
Minerva Neurosciences cash
Cash and short-term investments held at the end of each period.
Minerva Neurosciences's cash was $75.27M at Jun 30, 2026. For fiscal 2025 it was $82.30M, up 285.3% from the year before. Over ten years it grew 9.8% a year on average. The highest annual figure on record is $128.16M in fiscal 2017.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $82.30M | +285.3% |
| FY2024 | Dec 31, 2024 | $21.36M | -47.8% |
| FY2023 | Dec 31, 2023 | $40.91M | +13.4% |
| FY2022 | Dec 31, 2022 | $36.09M | -40.6% |
| FY2021 | Dec 31, 2021 | $60.76M | +139.6% |
| FY2020 | Dec 31, 2020 | $25.36M | -44.7% |
| FY2019 | Dec 31, 2019 | $45.85M | -47.9% |
| FY2018 | Dec 31, 2018 | $88.00M | -31.3% |
| FY2017 | Dec 31, 2017 | $128.16M | +54.3% |
| FY2016 | Dec 31, 2016 | $83.06M | +157.9% |
| FY2015 | Dec 31, 2015 | $32.20M | +73.7% |
| FY2014 | Dec 31, 2014 | $18.55M | +919.9% |
| FY2013 | Dec 31, 2013 | $1.82M | +807.7% |
| FY2012 | Dec 31, 2012 | $200.31K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $75.27M | +393.6% |
| Q1 FY2026 | Mar 31, 2026 | $78.06M | +351.5% |
| Q4 FY2025 | Dec 31, 2025 | $82.30M | +285.3% |
| Q3 FY2025 | Sep 30, 2025 | $12.29M | -53.7% |
| Q2 FY2025 | Jun 30, 2025 | $15.25M | -50.6% |
| Q1 FY2025 | Mar 31, 2025 | $17.29M | -50.3% |
| Q4 FY2024 | Dec 31, 2024 | $21.36M | -47.8% |
| Q3 FY2024 | Sep 30, 2024 | $26.53M | -43.4% |
| Q2 FY2024 | Jun 30, 2024 | $30.88M | -40.4% |
| Q1 FY2024 | Mar 31, 2024 | $34.82M | -3.2% |
| Q4 FY2023 | Dec 31, 2023 | $40.91M | +13.4% |
| Q3 FY2023 | Sep 30, 2023 | $46.90M | +16.6% |
| Q2 FY2023 | Jun 30, 2023 | $51.80M | +4.1% |
| Q1 FY2023 | Mar 31, 2023 | $35.98M | -34.5% |
| Q4 FY2022 | Dec 31, 2022 | $36.09M | -40.6% |
| Q3 FY2022 | Sep 30, 2022 | $40.22M | -38.7% |
| Q2 FY2022 | Jun 30, 2022 | $49.75M | -33.0% |
| Q1 FY2022 | Mar 31, 2022 | $54.95M | -31.4% |
| Q4 FY2021 | Dec 31, 2021 | $60.76M | +139.6% |
| Q3 FY2021 | Sep 30, 2021 | $65.59M | +101.7% |
| Q2 FY2021 | Jun 30, 2021 | $74.21M | +110.5% |
| Q1 FY2021 | Mar 31, 2021 | $80.14M | +113.6% |
| Q4 FY2020 | Dec 31, 2020 | $25.36M | -44.7% |
| Q3 FY2020 | Sep 30, 2020 | $32.52M | -45.7% |
| Q2 FY2020 | Jun 30, 2020 | $35.25M | -49.1% |
| Q1 FY2020 | Mar 31, 2020 | $37.51M | -52.6% |
| Q4 FY2019 | Dec 31, 2019 | $45.85M | -47.9% |
| Q3 FY2019 | Sep 30, 2019 | $59.93M | -38.6% |
| Q2 FY2019 | Jun 30, 2019 | $69.29M | -36.1% |
| Q1 FY2019 | Mar 31, 2019 | $79.16M | -34.6% |
| Q4 FY2018 | Dec 31, 2018 | $88.00M | -31.3% |
| Q3 FY2018 | Sep 30, 2018 | $97.61M | -26.6% |
| Q2 FY2018 | Jun 30, 2018 | $108.49M | +39.9% |
| Q1 FY2018 | Mar 31, 2018 | $121.00M | +41.7% |
| Q4 FY2017 | Dec 31, 2017 | $128.16M | +54.3% |
| Q3 FY2017 | Sep 30, 2017 | $132.93M | +44.7% |
| Q2 FY2017 | Jun 30, 2017 | $77.57M | – |
| Q1 FY2017 | Mar 31, 2017 | $85.36M | – |
| Q4 FY2016 | Dec 31, 2016 | $83.06M | – |
| Q3 FY2016 | Sep 30, 2016 | $91.85M | – |
See a number that looks wrong?